Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04140721
EARLY_PHASE1

Autonomic Determinants of POTS - Pilot 2

Sponsor: Vanderbilt University Medical Center

View on ClinicalTrials.gov

Summary

Postural tachycardia syndrome (POTS) is a relatively common condition affecting mostly otherwise healthy young women. These patients have high heart rate and disabling symptoms during standing. Quality of life may be poor. The sympathetic nerves in the autonomic nervous system help to maintain normal blood pressures and heart rates during activities of daily life. The purpose of this study is to determine the importance of sympathetic activation as a cause of orthostatic symptoms. The investigators will assess the effects of a blood pressure medication (Moxonidine) on the symptoms during standing. Moxonidine lowers sympathetic activity. The investigators believe patients with high resting sympathetic activity might benefit from Moxonidine. It might reduce high heart rate and improve symptoms during standing. This study should help clinicians and the growing population of patients with POTS gain a better understanding of this disorder and find more personalized treatment.

Official title: Autonomic Determinants of Postural Tachycardia Syndrome (Chronic Pilot Study 2)

Key Details

Gender

FEMALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2021-08-31

Completion Date

2026-12-31

Last Updated

2026-03-27

Healthy Volunteers

No

Interventions

DRUG

Placebo oral tablet

Placebo pill identical to moxonidine administered for 4 weeks

DRUG

Moxonidine Pill

Moxonidine pill administered for 4 weeks

Locations (1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States